<scp>HER2‐positive</scp> breast cancer brain metastasis: A new and exciting landscape
Alexandra S. Zimmer(Johns Hopkins University), Carey K. Anders(Duke University), Amanda E.D. Van Swearingen(Duke Cancer Institute)
Cited by 104
Related Papers
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
Brain metastases
|Nature Reviews Disease Primers|2019|1.1k
Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
|Journal of Clinical Oncology|2008|917
Breast Cancer Before Age 40 Years
|Seminars in Oncology|2009|795
Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
|Clinical Breast Cancer|2009|644